| abstract |
Provided is a fusion protein of an ETA antibody and a TGF-β Trap. Also provided is a pharmaceutical composition of the fusion protein of the ETA antibody and the TGF-β Trap. Further provided is a method for treating, preventing, or improving one or more symptoms of pulmonary arterial hypertension, pulmonary hypertension, pulmonary fibrosis, or cardiovascular fibrosis by using the fusion protein of the ETA antibody and the TGF-β Trap. |